Indian Pediatrics

, Volume 52, Issue 5, pp 385–389 | Cite as

Effect of pre-treatment nutritional status, folate and vitamin B12 levels on induction chemotherapy in children with acute lymphoblastic leukemia

  • Sneha Tandon
  • Nirmalya Roy Moulik
  • Archana Kumar
  • Abbas Ali Mahdi
  • Ashutosh Kumar
Research Paper



To evaluate pre-treatment undernutrition, and folate and B12 deficiency in children with acute lymphoblastic leukemia, and their correlation with complications and outcome of induction chemotherapy.


Observational study.


Tertiary care teaching hospital in Northern India.


50 children with acute lymphoblastic leukemia.


Children were assessed for nutritional status (Weight for age Z-score, serum albumin, folate and B12) at presentation, and were followed-up during induction for bone marrow response, counts and outcome. Folate and B12 were repeated twice at monthly intervals after induction. Univariate and multivariate analyses were done to determine the association of nutritional parameters with the outcome variables.


Baseline undernutrition was observed in 66%, hypoalbuminemia in 32.6%, folate deficiency in 41.3% and B12 deficiency in 36.9% of included children. Significant decline in folate levels was noted on serial assays during chemotherapy (P=0.001). Folate deficient children had higher risk for delayed marrow recovery and counts on day 14 (P=0.007 and P=0.001). Hypoalbuminemia (P=0.04), B12 deficiency (P=0.001) and folate (P=0.03) deficiency were associated with toxic deaths during induction.


Baseline nutritional deficiencies negatively influence the outcome and occurrence of complications during induction chemotherapy in children with acute lymphoblastic leukemia.


Acute leukemia Nutrition Outcome Protein energy malnutrition Vitamin deficiency 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Metzger ML, Howard SC, Fu LC, Peña A, Stefan R, Hancock ML et al. Outcome of childhood acute lymphoblastic leukaemia in resource-poor countries. Lancet. 2003;362:706–8.CrossRefPubMedGoogle Scholar
  2. 2.
    Reilly JJ, Weir J, McColl JH, Gibson BE. Prevalence of protein-energy malnutrition at diagnosis in children with acute lymphoblastic leukemia. J Pediatr Gastroenterol Nutr. 1999;29:194–7.CrossRefPubMedGoogle Scholar
  3. 3.
    Uderzo C, Rovelli A, Bonomi M, Barzaghi A, Strada S, Balduzzi A, et al. Nutritional status in untreated children with acute leukemia as compared with children without malignancy. J Pediatr Gastroenterol Nutr. 1996;23:34–7.CrossRefPubMedGoogle Scholar
  4. 4.
    Roy A, Saha A, Chakraborty S, Chattopadhyay S, Sur PK. Effects of pre-existing undernutrition on treatmentrelated complications and treatment outcomes in children with acute lymphoblastic leukemia: A tertiary care center experience. Clin Cancer Investig J. 2013;2:143–8.CrossRefGoogle Scholar
  5. 5.
    Linga VG, Shreedhara AK, Rau AT, Rau A. Nutritional assessment of children with hematological malignancies and their subsequent tolerance to chemotherapy. Ochsner J. 2012;12:197–201.PubMedCentralPubMedGoogle Scholar
  6. 6.
    World Bank. Undernutrtion Report; South Asia-India. Available from:,,contentmdk:20916955!~pagepk:146736~pipk:146830~thesitepk:223547,00.html. Accessed December 3, 2014.Google Scholar
  7. 7.
    Taneja S, Bhandari N, Strand TA, Sommerfelt H, Refsum H, Ueland PM, et al. Cobalamin and folate status in infants and young children in a low-to-middle income community in India. Am J Clin Nutr. 2007;86:1302–9.PubMedGoogle Scholar
  8. 8.
    Sadananda Adiga MN, Chandy S, Ramaswamy G, Appaji L, Krishnamoorthy L. Homocysteine, vitamin B12 and folate status in pediatric acute lymphoblastic leukemia. Indian J Pediatr. 2008;75:235–8.CrossRefPubMedGoogle Scholar
  9. 9.
    Branda RF, Nigels E, Lafayette AR, Hacker M. Nutritional folate status influences the efficacy and toxicity of chemotherapy in rats. Blood. 1998;92:2471–6.PubMedGoogle Scholar
  10. 10.
    Ortiz Z, Shea B, Suarez Almazor M, Moher D, Wells G, Tugwell P. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. Cochrane Database Syst Rev. 2000:CD000951.Google Scholar
  11. 11.
    Erkurt MA, Aydogdu I, Dikilitaº M, Kuku I, Kaya E, Bayraktar N, et al. Effects of cyanocobalamin on immunity in patients with pernicious anemia. Med Princ Pract. 2008;17:131–5.CrossRefPubMedGoogle Scholar
  12. 12.
    Asim M, Zaidi A, Ghafoor T, Qureshi Y. Death analysis of childhood acute lymphoblastic leukaemia; experience at Shaukat Khanum Memorial Cancer Hospital and Research Centre, Pakistan. J Pak Med Assoc. 2011;61:666–70.PubMedGoogle Scholar
  13. 13.
    Gupta S, Antillon FA, Bonilla M, Fu L, Howard SC, Ribeiro RC, et al. Treatment-related mortality in children with acute lymphoblastic leukemia in Central America. Cancer. 2011;117:4788–95.CrossRefPubMedGoogle Scholar
  14. 14.
    de Benoist B. Conclusions of a WHO Technical Consultation on folate and vitamin B12 deficiencies. Food Nutr Bull. 2008;29:S238–44.Google Scholar
  15. 15.
    Kumar N, Gupta N, Kishore J. Kuppuswamy’s socioeconomic scale: Updating income ranges for the year 2012. Indian J Public Health. 2012;56:103–4.CrossRefPubMedGoogle Scholar
  16. 16.
    Common Terminology Criteria for Adverse Events version 4.0 (NCI-CTCAE v4.0)–National Cancer institute.Google Scholar
  17. 17.
    Kumar R, Marwaha RK, Bhalla AK, Gulati M. Protein energy malnutrition and skeletal muscle wasting in childhood acute lymphoblastic leukemia. Indian Pediatr. 2000;37:720–6.PubMedGoogle Scholar
  18. 18.
    Khan AU, Sheikh MU, Intekhab K. Pre-existing malnutrition and treatment outcome in children with acute lymphoblastic leukaemia. J Pak Med Assoc. 2006;56:171–3.PubMedGoogle Scholar
  19. 19.
    Graham ML, Shuster JJ, Kamen BA, Cheo DL, Harrison MP, Leventhal BG, et al. Red blood cell methotrexate and folate levels in children with acute lymphoblastic leukemia undergoing therapy: A Pediatric Oncology Group pilot study. Cancer Chemother Pharmacol. 1992;31:217–22.CrossRefPubMedGoogle Scholar
  20. 20.
    Sterba J, Dusek L, Demlova R, Valik D. Pretreatment plasma folate modulates the pharmacodynamic effect of high-dose methotrexate in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma: “folate overrescue” concept revisited. Clin Chem. 2006;52:692–700.CrossRefPubMedGoogle Scholar
  21. 21.
    Skärby TV, Anderson H, Heldrup J, Kanerva JA, Seidel H, Schmiegelow K, et al. Nordic Society of Paediatric Haematology and Oncology (NOPHO). High leucovorin doses during high-dose methotrexate treatment may reduce the cure rate in childhood acute lymphoblastic leukemia. Leukemia. 2006;20:1955–62.Google Scholar
  22. 22.
    Krishnaswamy K, Madhavan Nair K. Importance of folate in human nutrition. Br J Nutr. 2001;85:S115–24.CrossRefGoogle Scholar
  23. 23.
    Scagliotti GV, Shin DM, Kindler HL, Vasconcelles MJ, Keppler U, Manegold C, et al. Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma. J Clin Oncol. 2003;21:1556–61.CrossRefPubMedGoogle Scholar
  24. 24.
    Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol. 2003;21:2636–44.CrossRefPubMedGoogle Scholar

Copyright information

© Indian Academy of Pediatrics 2015

Authors and Affiliations

  • Sneha Tandon
    • 1
  • Nirmalya Roy Moulik
    • 1
  • Archana Kumar
    • 1
  • Abbas Ali Mahdi
    • 2
  • Ashutosh Kumar
    • 3
  1. 1.Departments of PediatricsKing George’s UniversityLucknowIndia
  2. 2.Departments of BiochemistryKing George’s UniversityLucknowIndia
  3. 3.Departments of Hemato-pathologyKing George’s UniversityLucknowIndia

Personalised recommendations